We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Rush Enterprises Class A
RUSHA
$9.62B
| $1.1M | ﹤0.01% |
20,139
-1,300
| -6% | -$74.2K |
|
927
American Healthcare REIT
AHR
$10.3B
| $1.1M | ﹤0.01% |
+38,800
| New | +$1.04M |
|
928
Highwoods Properties
HIW
$3.51B
| $1.1M | ﹤0.01% |
36,023
-4,800
| -12% | -$156K |
|
929
Choice Hotels
CHH
$4.71B
| $1.09M | ﹤0.01% |
7,651
-2,000
| -21% | -$283K |
|
930
Plexus
PLXS
$7.04B
| $1.09M | ﹤0.01% |
6,937
+700
| +11% | +$107K |
|
931
Urban Outfitters
URBN
$6.53B
| $1.08M | ﹤0.01% |
19,753
-1,100
| -5% | -$47K |
|
932
Arcosa
ACA
$7.12B
| $1.08M | ﹤0.01% |
11,200
+1,300
| +13% | +$131K |
|
933
Broadstone Net Lease
BNL
$4.35B
| $1.08M | ﹤0.01% |
68,200
+5,500
| +9% | +$95.9K |
|
934
Perrigo
PRGO
$1.78B
| $1.08M | ﹤0.01% |
42,100
+5,100
| +14% | +$134K |
|
935
PTC Therapeutics
PTCT
$6.01B
| $1.07M | ﹤0.01% |
23,800
-900
| -4% | -$38.5K |
|
936
Thor Industries
THO
$4.11B
| $1.07M | ﹤0.01% |
11,223
| – | – |
|
937
Fox Class B
FOX
$24.4B
| $1.07M | ﹤0.01% |
+23,384
| New | +$985K |
|
938
Stride
LRN
$3.48B
| $1.07M | ﹤0.01% |
10,300
+2,600
| +34% | +$247K |
|
939
Cedar Fair
FUN
$1.71B
| $1.06M | ﹤0.01% |
+22,100
| New | +$969K |
|
940
Mirion Technologies
MIR
$3.88B
| $1.06M | ﹤0.01% |
61,031
+5,800
| +11% | +$90K |
|
941
American States Water
AWR
$3.52B
| $1.06M | ﹤0.01% |
13,687
+1,011
| +8% | +$84.2K |
|
942
Harley-Davidson
HOG
$2.9B
| $1.06M | ﹤0.01% |
35,323
+3,100
| +10% | +$103K |
|
943
Newell Brands
NWL
$2.63B
| $1.06M | ﹤0.01% |
106,200
+4,900
| +5% | +$44.4K |
|
|
CWAN
944
DELISTED
Clearwater Analytics
CWAN
| $1.06M | ﹤0.01% |
38,400
+11,300
| +42% | +$321K |
|
945
Construction Partners
ROAD
$6.73B
| $1.05M | ﹤0.01% |
11,900
-500
| -4% | -$43.5K |
|
|
MZTI
946
The Marzetti Company
MZTI
$3.22B
| $1.05M | ﹤0.01% |
6,072
-200
| -3% | -$36.6K |
|
947
Installed Building Products
IBP
$6.54B
| $1.04M | ﹤0.01% |
5,965
+400
| +7% | +$87K |
|
948
Dorman Products
DORM
$3.95B
| $1.04M | ﹤0.01% |
8,044
+800
| +11% | +$102K |
|
949
BridgeBio Pharma
BBIO
$15.9B
| $1.04M | ﹤0.01% |
37,950
+5,400
| +17% | +$140K |
|
950
Flowers Foods
FLO
$1.6B
| $1.04M | ﹤0.01% |
50,406
+1,300
| +3% | +$28.6K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.